As the global economy mends, the 2021 growth of Cefepime will have significant change from previous year. According to our (LP Information) latest study, the global Cefepime market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cefepime market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Cefepime market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cefepime market, reaching US$ million by the year 2028. As for the Europe Cefepime landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cefepime players cover Baxter, Apotex, B. Braun Medical, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cefepime market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Intramuscular Injection
Intravenous Drug Delivery
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Lower Respiratory Tract Infection
Urinary Tract Infection
Skin And Soft Tissue Infections
Abdominal Cavity Infection
Gynecologic Infection
Sepsis
Neutrophilic Fever
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Baxter
Apotex
B. Braun Medical
Pfizer
Perrigo
Fresenius Kabi
Sandoz (Novartis)
Piramal Critical Care
Meitheal Pharmaceuticals
BMS
Qilu Pharmaceutical
Sinopharm
Shanghai Xinfeng Pharmaceutical
Hebei Huamin Pharmaceutical
Nanjing Haichen Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangzhou Baiyunshan Tianxin Pharmaceutical
Yuekang Pharmaceutical Group
Chengdu Beite Pharmaceutical
Jiangsu Hengrui Pharmaceutical
Hainan Star Pharmaceutical
Hainan Hailing Pharmaceutical
Shenzhen Xinlitai Pharmaceutical
Shenzhen Lijian Pharmaceutical
Suzhou Dongrui Pharmaceutical